HAPILA brings API manufacturing solutions to Chemspec Europe 2022

news-releasesHAPILA GmbH

July 8th 2022

Gera, Germany: – High-potency active ingredient specialist CDMO HAPILA GmbH (HAPILA) made a highly successful showing at the recently reconvened physical Chemspec Europe trade show in Frankfurt.

HAPILA has been a consistent presence at Chemspec since 2015 and was again an exhibitor this year, as a featured partner on a stand jointly shared with other German companies active in the API and Fine Chemical fields.

Meeting supply needs

The HAPILA team at Chemspec was led by CEO Dr. Uwe Müller, who reports that more severe supply chain problems in the wake of the Covid pandemic has increased interest in finding reliable CMOs to undertake multistep chemical synthesis and GMP-manufacturing.

“Some pharmaceutical companies are looking for European and particularly German partners to fulfill all work related to high potency APIs to solve their technical and capacity problems,” said Dr. Müller.

“In this regard, we were able to have many very interesting conversations based on our long experience and advanced facilities,” he added.

Advanced manufacturing

HAPILA was active in networking across the Chemspec show, with offers that highlighted the company’s advanced technical abilities in small molecule development and manufacturing, along with high degree of flexibility and responsiveness in solving specific customer problems.

“It was my impression that many senior pharma professionals came to Chemspec 2022 looking to find an experienced and reliable partner to solve their development and GMP manufacturing API-issues and quite a few of them were plainly impressed with what we can offer,” said Dr. Müller .

“They brought us interesting challenges and already we were able to suggest promising approaches,” he reported.

About HAPILA GmbH

HAPILA GmbH is a Contract developer and manufacturer (CDMO) that provides high-value services to pharma, biotech and fine chemicals client companies in the development and cGMP manufacture.

HAPILA is an independent company with particular experience in GMP-related development and GMP manufacturing, offering full regulated service for API (IMPD, ASMF) to very high scientific and quality assurance (QA) levels.

It supports the development and manufacture of drug products with patented processes and in-depth experience in the API value-creation chain from synthesis through purification to particle design.

The company’s mission is to supply exclusive products of highest quality, potency and safety in compliance with GMP and environmental protection guidelines. All HAPILA teamwork is focused on product quality and customer satisfaction.

All HAPILA chemical synthesis is carried out at in-house at its GMP certified laboratories and pilot plants at Gera, Thuringia, in east-central Germany.

When combined with purification and particle design, HAPILA’s chemical synthesis services cover the complete API value-creation chain, enabling it to be a highly efficient bridge-builder between API production and pharmaceutical end-use.

For more information, visit: https://www.hapila.de/en

About Chemspec Europe 2022

The International Exhibition for Fine and Specialty Chemicals, Chemspec Europe, is the continent’s premier sourcing and networking event for manufacturers, suppliers and distributors of fine and specialty chemicals. Chemspec Europe is renowned for its specialized profile, presenting visitors and exhibitors with a platform to share knowledge about products and solutions.

The 35^th Chemspec Europe expo (Chemspec 2022) was a two-day event opening May 31 at the Messe Exhibition Center in Frankfurt, Germany, reconfigured as a full physical event for the first time since 2019, having moved online during the global coronavirus pandemic.

Chemspec 2022 was attended by more than 5,000 industry professionals from all over the world and featured almost 290 exhibitors from some 30 countries worldwide.

The event is organized by Mack-Brooks Exhibitions with further information at https://www.chemspeceurope.com